GlassScriptPhysician profile
Arti A Patel
NPI 1275662280
$9,079.02
in general payments reported to CMS, 2019-2025
57 companies · $2,209 in 2025
The $2,209 reported for 2025 was more than what 78% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,505 · 2020: $393 · 2021: $523 · 2022: $1,084 · 2023: $1,479 · 2024: $1,886 · 2025: $2,209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,396 · Travel and Lodging: $1,158 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,395.81 |
| Travel and Lodging | $1,158.19 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,921.90 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Novo Nordisk INC | $862.20 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $541.53 | 2019-2025 | Mounjaro, Jardiance, Baqsimi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $500.75 | 2019-2025 | Jardiance |
| Amgen INC. | $479.60 | 2019-2025 | Evenity, Prolia, Repatha |
| Dexcom, INC. | $451.40 | 2019-2024 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $449.06 | 2019-2025 | |
| Abbvie INC. | $357.47 | 2019-2025 | |
| Abbott Laboratories | $317.18 | 2019-2025 | Freestyle Libre 3 |
| Tandem Diabetes Care, INC. | $303.53 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Astrazeneca Pharmaceuticals LP | $296.34 | 2019-2025 | Farxiga |
| Ibsa Pharma INC. | $285.78 | 2019-2025 | Tirosint, Licart, Licart |
| Alexion Pharmaceuticals, INC. | $178.55 | 2019-2025 | Strensiq |
| Xeris Pharmaceuticals, INC. | $164.58 | 2022-2024 | Gvoke Hypopen, Recorlev |
| Mannkind Corporation | $163.89 | 2021-2024 | Afrezza |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $124.51 | 2019-2025 | Korlym |
| Insulet Corporation | $121.90 | 2019-2025 | Omnipod |
| Kyowa Kirin, INC. | $104.04 | 2023-2024 | Crysvita |
| Bayer Healthcare Pharmaceuticals INC. | $98.81 | 2021-2025 | |
| Acella Pharmaceuticals, LLC | $97.15 | 2022-2024 | NP Thyroid 60 |
| Vivus LLC | $84.16 | 2019-2023 | Qsymia |
| Ascensia Diabetes Care US INC. | $80.41 | 2022-2024 | |
| Amneal Pharmaceuticals LLC | $67.05 | 2019-2021 | |
| Amarin Pharma, INC. | $66.17 | 2019-2022 | |
| Medtronic Minimed, INC. | $64.07 | 2019-2020 | |
| Radius Health, INC. | $55.17 | 2019 | |
| Janssen Pharmaceuticals, INC | $53.04 | 2019-2020 | |
| Recordati_rare_diseases_inc. | $50.50 | 2023-2024 | Isturisa, Signifor Lar |
| Beta Bionics, INC. | $41.22 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Antares Pharma, INC. | $40.94 | 2024 | Xyosted |
| Horizon Therapeutics Plc | $35.48 | 2019-2021 | |
| Eisai INC. | $34.83 | 2019 | |
| Becton, Dickinson and Company | $33.36 | 2021-2022 | |
| Nevro Corp. | $33.26 | 2022 | |
| Currax Pharmaceuticals LLC | $32.87 | 2020-2022 | |
| Lifescan, INC. | $32.75 | 2021-2022 | |
| Companion Medical, INC. | $32.47 | 2019 | |
| Cequr Corporation | $30.45 | 2021-2023 | Cequr Simplicity |
| Tolmar, INC. | $29.17 | 2023-2025 | Jatenzo |
| Regeneron Healthcare Solutions, INC. | $27.51 | 2019 | |
| Shire North American Group INC | $27.26 | 2019 | |
| Electromed, INC. | $26.97 | 2025 | Smartvest |
| Novartis Pharmaceuticals Corporation | $24.85 | 2022 | |
| Sequel Med Tech, LLC | $24.70 | 2025 | Twiist |
| Amphastar Pharmaceuticals, INC. | $23.29 | 2024 | |
| Pfizer INC. | $21.91 | 2024 | |
| Zealand Pharma US, INC. | $21.61 | 2021 | |
| Merck Sharp & Dohme LLC | $21.24 | 2023 | Steglujan, Segluromet, Steglatro |
| Bigfoot Biomedical INC | $20.01 | 2022 | |
| Amryt Pharma Holdings LTD | $19.98 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.42 | 2022 | |
| Intuity Medical INC | $17.14 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Nalpropion Pharmaceuticals LLC | $17.02 | 2019 | |
| Vifor Pharma, INC. | $14.50 | 2019 | |
| Alfasigma USA, INC. | $12.76 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $11.41 | 2020 | |
| Valeritas, INC. | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arti Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.